Astrocyte Pharmaceuticals
A Novel Approach to Neuroprotection
Groton, United States
12 employees
Series B
Total: $37.21M
Biotechnology, Health and Wellness +1
General Information
Groton, United States
BounceWatch is an independent company data service, not affiliated with Astrocyte Pharmaceuticals. To contact Astrocyte Pharmaceuticals, visit astrocytepharma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Astrocyte Pharmaceuticals compare?
A PDF of Astrocyte Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Astrocyte Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Astrocyte Pharmaceuticals on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Astrocyte Pharmaceuticals
Business keywords: Neuroprotection, Drug discovery, Clinical-stage, Mitochondrial energy, Astrocytes, Brain injury, Stroke, TBI, Concussion, Neurodegenerative disorders, Alzheimer's disease, Therapeutic agents, Neuroprotection research, Cerebroprotective, Clinical trials
Funding Rounds & Investors (13)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $6.00M | 10 |
|
18 Aug 2023 |
| Debt Financing | $2.84M | - |
|
27 Oct 2022 |
| Grant | $500.00K | 2 |
Medical Technology Enterprise Consortium, BrightFocus Foundation
|
08 Sep 2021 |
| Series A | $6.00M | 10 |
|
03 May 2021 |
| Series A | Undisclosed | - |
|
05 Apr 2021 |
| Venture Round | $7.52M | - |
|
10 Dec 2020 |
| Series A | $5.00M | 1 |
|
30 Nov 2020 |
| Grant | $3.00M | 1 |
Small Business Innovation Research
|
19 Sep 2018 |
| Grant | $287.00K | 1 |
National Institute on Aging
|
18 Sep 2018 |
| Seed Round | $2.30M | 6 |
|
06 Jun 2018 |
Astrocyte Pharmaceuticals Alternatives & Competitors
View All Alternatives
Transforming how we treat Alzheimer’s, Parkinson’s, and beyond.
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative diseases.
Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and...
FAQ About Astrocyte Pharmaceuticals
Source: BounceWatch company record for Astrocyte Pharmaceuticals, https://bouncewatch.com/company/astrocyte-pharmaceuticals, updated 12 September 2024. When citing, please name BounceWatch and link this page.
